Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer…
NCT00002631 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002631 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus |
| Official title | A PHASE III INTERGROUP RANDOMIZED COMPARISON OF COMBINED MODALITY THERAPY FOR CARCINOMA OF THE ESOPHAGUS: HIGH-DOSE VS CONVENTIONAL-DOSE RADIATION THERAPY |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group North Central Cancer Treatment Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Radiation |
| Interventions | chemotherapy, cisplatin, fluorouracil, low-LET electron therapy, low-LET photon therapy |
| Enrollment | 298 |
| Start date | Jun 1, 1995 |
| Primary completion | Sep 1, 1999 |
| First posted | Aug 31, 2004 |
| Last update posted | Nov 19, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: